Emerging Clinical Diagnostics Laboratory – Built for Scale | $4–$5M Revenue Growth Potential

This is a rare opportunity to acquire a fully credentialed clinical medical laboratory in its early growth stage, strategically positioned to scale to $4–$5 million in annual revenue within the next 24 months under focused business development and payer expansion.

Importantly, this is not a startup concept — it is an operational, credentialed lab platform. The infrastructure, licensing, equipment, and compliance foundation are already in place. Replicating this build-out from scratch would conservatively exceed $4 million in capital investment, making this a true replacement-cost opportunity with substantial upside.

Business Overview

This clinical laboratory provides a wide range of diagnostic testing services used by healthcare providers to diagnose, monitor, and screen for health conditions. The lab is:

Registered with an active NPI (National Provider Identifier)

Operating under CLIA certification

Approved to perform regulated clinical laboratory testing

The platform is structured for expansion, not stabilization — presenting a growth-oriented acquisition opportunity.

Services & Capabilities

The lab currently offers a broad testing menu, including:

Genetic and molecular diagnostics

Routine clinical testing

Clinical toxicology

Allergy testing

COVID-19 testing

Regulatory listings allow testing across multiple disciplines, including:

Bacteriology

Clinical chemistry

Immunology (serology)

Endocrinology

Hematology

Toxicology

Urinalysis

Virology

This diversified testing capability supports scalability across multiple provider verticals.

Clinical Credentials

The laboratory team includes:

Board-certified pathologists

Ph.D.-level professionals with credentials in molecular diagnostics

Qualified clinical laboratory personnel

The lab emphasizes competitive turnaround times and flexible provider ordering/reporting systems, creating a scalable provider-facing platform.

Location & Market

Located in Central New Jersey, servicing healthcare providers throughout New York and New Jersey — two of the most regulated and high-value healthcare markets in the country.

Growth Opportunity- ASSET SALE

This lab is in its infancy operationally but fully built structurally. Key growth drivers include:

Expansion of provider network

Increased specimen volume

Strategic payer contracting

Sales force deployment

Targeted specialty testing expansion

With proper capitalization and business development, the platform is positioned for significant near-term revenue growth.

Ideal Buyer

Strategic laboratory operators

Healthcare investors

Private equity groups

Physician groups seeking vertical integration

Healthcare consolidators

Confidential offering. Financials, payer mix, equipment schedules, and regulatory documentation available upon NDA.